The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia
- PMID: 20851119
- DOI: 10.1016/j.expneurol.2010.09.008
The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia
Abstract
Deficits in executive functions are key features of schizophrenia. Rodent behavioral paradigms used so far to find animal correlates of such deficits require extensive effort and time. The puzzle box is a problem-solving test in which mice are required to complete escape tasks of increasing difficulty within a limited amount of time. Previous data have indicated that it is a quick but highly reliable test of higher-order cognitive functioning. We evaluated the use of the puzzle box to explore executive functioning in five different mouse models of schizophrenia: mice with prefrontal cortex and hippocampus lesions, mice treated sub-chronically with the NMDA-receptor antagonist MK-801, mice constitutively lacking the GluA1 subunit of AMPA-receptors, and mice over-expressing dopamine D2 receptors in the striatum. All mice displayed altered executive functions in the puzzle box, although the nature and extent of the deficits varied between the different models. Deficits were strongest in hippocampus-lesioned and GluA1 knockout mice, while more subtle deficits but specific to problem solving were found in the medial prefrontal-lesioned mice, MK-801-treated mice, and in mice with striatal overexpression of D2 receptors. Data from this study demonstrate the utility of the puzzle box as an effective screening tool for executive functions in general and for schizophrenia mouse models in particular.
Published by Elsevier Inc.
Similar articles
-
Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.Neuron. 2006 Feb 16;49(4):603-15. doi: 10.1016/j.neuron.2006.01.023. Neuron. 2006. PMID: 16476668
-
Modulation of hippocampus-prefrontal cortex synaptic transmission and disruption of executive cognitive functions by MK-801.Cereb Cortex. 2015 May;25(5):1348-61. doi: 10.1093/cercor/bht329. Epub 2013 Dec 4. Cereb Cortex. 2015. PMID: 24304584
-
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.Neuropsychopharmacology. 2007 Jan;32(1):17-34. doi: 10.1038/sj.npp.1301188. Epub 2006 Aug 23. Neuropsychopharmacology. 2007. PMID: 16936709
-
[Cognition, schizophrenia and the effect of antipsychotics].Encephale. 2006 May-Jun;32(3 Pt 1):341-50. doi: 10.1016/s0013-7006(06)76162-0. Encephale. 2006. PMID: 16840928 Review. French.
-
The effect of non-competitive NMDA receptor antagonist MK-801 on neuronal activity in rodent prefrontal cortex: an animal model for cognitive symptoms of schizophrenia.J Physiol Paris. 2013 Dec;107(6):448-51. doi: 10.1016/j.jphysparis.2013.04.003. Epub 2013 Apr 18. J Physiol Paris. 2013. PMID: 23603055 Review.
Cited by
-
Imbalanced post- and extrasynaptic SHANK2A functions during development affect social behavior in SHANK2-mediated neuropsychiatric disorders.Mol Psychiatry. 2021 Nov;26(11):6482-6504. doi: 10.1038/s41380-021-01140-y. Epub 2021 May 21. Mol Psychiatry. 2021. PMID: 34021263 Free PMC article.
-
Nasal administration of mesenchymal stem cells restores cisplatin-induced cognitive impairment and brain damage in mice.Oncotarget. 2018 Oct 30;9(85):35581-35597. doi: 10.18632/oncotarget.26272. eCollection 2018 Oct 30. Oncotarget. 2018. PMID: 30473752 Free PMC article.
-
Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology.Hum Mol Genet. 2012 Jan 15;21(2):344-57. doi: 10.1093/hmg/ddr470. Epub 2011 Oct 12. Hum Mol Genet. 2012. PMID: 21994763 Free PMC article.
-
Cre-Activation in ErbB4-Positive Neurons of Floxed Grin1/NMDA Receptor Mice Is Not Associated With Major Behavioral Impairment.Front Psychiatry. 2021 Nov 25;12:750106. doi: 10.3389/fpsyt.2021.750106. eCollection 2021. Front Psychiatry. 2021. PMID: 34899420 Free PMC article.
-
HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity.Theranostics. 2022 Jan 1;12(2):603-619. doi: 10.7150/thno.67410. eCollection 2022. Theranostics. 2022. PMID: 34976203 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical